B & C Biopharm

Company Description

B&C Biopharm(The treatment of fatty liver diseaseSafety: three phases of preclinical trials and many number of participants for clinical tests of Dr. J confirm its safety. Due to the fact that Dr. J has been developed as a pharmaceutical drug, bio-transformed Ginsenosides completed three phases of preclinical trials, which the FDA does not require for the approval of health functional food but for medicines. Clinical trials of Dr. J was practiced with 100 subjects although required numbers of participants are 40. For instance, clinical studies for the safety of genus hovenia was practiced with 40 participants.

Company Information

  • Contact Person:: Ms.Linda yang (Man
  • Telephone:
  • Business Type:Manufacturing
  • Year Established:1999
  • Number Of Employees:11-15
  • Trade Capacity:Export Percentage:
  • Main Products:Dr. J Is Health Functional Food For Liver Health, Which Made By Platycodon Root Extract.,
  • Address:South Korea
  • Main Markets:Asia,America
  • Website:Visit website
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries